is involved in the pathogenesis of gastritis, peptic ulcer disease and gastric adenocarcinoma. In addition, a causal Helicobacter pylori role of infection in the development of primary gastric extranodal marginal zone lymphoma of Mucosa-Associated Lymphoid H. pylori Tissue (MALT) is now well established. Indeed, the eradication of infection leads to a regression of Gastric MALT Lymphoma H. pylori (GML) in 75 of the cases.
%
The clinical evolution of patients responding to eradication or to chemotherapy is usually favourable. However histological H. pylori monitoring of GML patients has shown a higher incidence of corpus predominant and pangastric atrophy with intestinal metaplasia as well as an evolution to gastric adenocarcinoma in a limited number of cases. The development of gastric adenocarcinoma at the initial location of the lymphoma suggests that the process of carcinogenesis is favoured by the persistence of a residual disease.
Chronic gastric inflammation may certainly lead to an increased production of reactive oxygen species (ROS) implying the NOX family of superoxide-generating NADPH oxidases. Indeed, Salles . showed that NOX family (NOX2 and NOX5) was expressed in et al human stomach biopsies and was associated with the severity of inflammation and atrophic gastric lesions ( ). 8
The NOX family consists of multiple members, including NOX2 and NOX5. The NOX2 enzyme is traditionally referred to as the gp91phox subunit of the phagocyte NADPH oxidase as white blood cells of myeloid lineage are the predominant site of expression.
" " NOX2 is without a doubt an enzyme involved in host defense. NOX5 is essentially found in lymphoid tissue but not in circulating lymphocytes; NOX5 is enriched/abundant in B cell rich regions surrounding germinal centers, as well as in T cell rich regions.
Based on the fact that 1) NOX5 is generally found in lymphoid tissue ( ) and 2) tumor cells of hairy cell leukemia express NOX5 ( ), 1 5
we decided to explore NOX5 expression in GML patients. Furthermore, since GML is associated with infection and an H. pylori inflammatory immune response, NOX2 expression was studied as well. As a result, the aim of this study was to quantify NOX2 and NOX5 mRNA expression in GML biopsies compared to chronic gastritis biopsies in order to establish a potential link between NOX activity and GML development.
The clinical data, status, histopathological (Sydney system) and molecular features of gastric biopsies of GML patients and H. pylori controls are summarized in . Table 1 
GML patients
Nineteen of 39 GML patients were positive at the time of diagnosis. One of them had a past history of infection but H. pylori H. pylori was negative at the time of the gastric biopsy used for this study. Most patients presented with localized disease (n 23) while 9 and 7 = patients were stage IIE and IV, respectively. In 17 patients, the t(11;18)( ) translocation was detected in tumour cells.
API2-MALT1
Eighteen patients received antitreatment and 5 of them were in remission of the disease at the end of the treatment. These 5 H. pylori patients had t(11;18) negative GML.
The remaining patients were treated with either chlorambucil alone, rituximab alone, or a combination of rituximab chlorambucil as -previously described.
After a median follow-up of 3 years (range 0 20 years), 30 patients were in histological remission (9 Complete Remission (CR), 21 -probable Minimal Residual Disease (pMRD) according to the GELA score), 5 were in partial remission (responding Residual Disease (rRD)), three patients presented persisting disease (No Change (NC)) and one patient was lost to follow-up.
Gastritis patients
In the control group, 17 out of 43 were positive.
H. pylori
Comparison of the Sydney score between GML patients at diagnosis and the control group
The percentages of activity, inflammation, atrophy and intestinal metaplasia observed in gastric biopsies of GML patients and in the control group were compared following the updated Sydney System for the classification of gastritis. A statistical difference was found for inflammation ( 6.23) and for intestinal metaplasia ( 3.86). Inflammation was significantly higher in the control group than in X 2 = X 2 = GML patients, and intestinal metaplasia was significantly higher in GML patients than in the control group. None of the patients with GML or in the control group had gastric dysplasia.
NOX expression according to H. pylori status
NOX2 and NOX5 were detected in all biopsies included in the present study. Considering all of the biopsies, NOX2 expression was almost 167 times higher than NOX5 expression: NOX2 relative mRNA levels: 0.212 0.532, and NOX5: 0.001 0.003. NOX2 and NOX5
± ± gastric mRNA expression were positively correlated (r 0.36, p 0.001) ( ). = = Figure 1 No difference was observed in NOX2 and NOX5 expression according to status in GML patients (p 0.633 and p 0.620, H. pylori = = respectively) ( ). Considering gastritis patients, there was also no difference in NOX2 expression and status (p 0.441). Figure 2A H. pylori = However, NOX5 expression was less important in negative gastritis patients than in positive gastritis patients (p 0.001) Figure 2B NOX expression in GML patients compared to gastritis patients NOX2 expression increased significantly in GML patients compared to gastritis patients (p<0.0001), whereas NOX5 expression did not vary between these two populations (p 0.149) ( ). NOX2 expression was also significantly lower in gastric biopsies obtained = Figure 3 from 10 patients after lymphoma remission whereas NOX5 expression did not vary (p<0.0001 and p 0.45, respectively) ( ). 
NOX expression according to the presence of the t(11;18) translocation in GML patients
There was no association between NOX2 (p 0.301) or NOX5 expression (p 0.581) and the presence of the t(11;18) translocation (p
0.966 and p 0.166, respectively).
=

NOX expression according to the Sydney system
Mean values of NOX2 and NOX5 expression according to the Sydney system are presented in . No difference was found Table 2 between NOX2 and NOX5 expression and the score of the different histopathological parameters, i.e. activity, inflammation, atrophy and intestinal metaplasia.
The aim of the present study was to investigate the putative role of the NOX family of superoxide-generating NADPH oxidases in the process of GML development and occurrence of preneoplastic lesions (atrophy and intestinal metaplasia). We focused on the expression of NOX2 and NOX5 mRNA in GML biopsies compared to biopsies from gastritis patients as the control group. Presented data are primary data; further studies are needed using 1) immunohistochemistry in order to identify the nature of NOX2 and NOX5 producing cells and 2) ROS measurement.
In the present study, the cases and controls were not chosen randomly but we deliberately included a high proportion of H. pylori negative in both groups in order to be able to compare the impact of status. An association between NOX2 expression and gastric H. pylori MALT lymphoma is shown for the first time.
In both groups of patients, high levels of NOX were found which may reflect the recruitment of polynuclear and mononuclear cells in gastric mucosa which can therefore influence the inflammatory response. However, there was no correlation between status and H. pylori NOX2 expression, hence the NOX2 expression levels merely reflect the innate immune response rather than the adaptive immune response of the gastric mucosa. In contrast, NOX5 expression is significantly lower in infected gastritis patients. Indeed H. pylori H. pylori γ -glutamyl transpeptidase (GGT) ( ), and the VacA cytotoxin described as a ubiquitous immunosuppressive factor for the bacteria ( ) 9 3 inhibit T lymphocyte proliferation and are of major importance in gastric colonization and persistence of the infection, explaining the NOX5 expression decrease. The inverse correlation between NOX5 and status found in gastritis patients but not in gastric MALT H. pylori lymphoma patients may be explained by the fact that tumor infiltrating T lymphocytes do not recognize the same antigens as gastritis T lymphocytes and are already engaged in a cross talk with B lymphocytes ( ). GML patients showed higher NOX2 expression than 4 gastritis patients. NOX2 expression significantly decreased after lymphoma remission. No association was found between NOX2 levels and t(11;18) suggesting that NOX2 do not play a major role in the occurrence of GML-associated cytogenetic abnormalities.
The exact type of NOX2 producing cells remains to be determined and whether NOX2 production is related to cells of the GML producing NOX in human GML.
The second aim of this study was to consider the potential role of NOX in the development of preneoplastic lesions in GML. Previous studies conducted by our group have shown that GML patients develop significantly more preneoplastic lesions, e.g. atrophy and intestinal metaplasia during the follow-up period as compared to patients with non-ulcer dysplasia. Similar results were observed in the present study with GML patients showing an elevated percentage of intestinal metaplasia (7 ) as compared to the control group (4 ). It is % % therefore tempting to speculate that NOX2 may have a significant impact on the development of preneoplastic lesions in the context of GML but further studies are needed using immunohistochemistry in order to better understand the pathogenesis.
In conclusion, this is the first study to demonstrate an association between NOX2 expression in a large series of GML patients when compared to a gastritis control group. Further studies are ongoing to identify the nature of the NOX2 producing cells which may be either GML tumor cells or cells from the immune microenvironment.
Innovation
For the first time, NOX expression was studied directly on human stomach biopsies issued from patients suffering from GML or gastritis. Interestingly, we found that NOX2 expression was higher in GML patients as compared to the control group and that NOX2 expression decreased with the remission of the disease. These results raise the question of the potential role of NOX2 in the development of GML and associated preneoplastic lesions, namely atrophy and intestinal metaplasia which have been shown to be increased in the context of GML.
Notes Material and methods
Patients
Thirty-nine patients (23 men, 16 women; median age 57.5 years, range 24 80 years) with primary GML treated and followed from Tumors were graded according to the Ann Arbor system, modified by Musshof. The initial evaluation included blood tests for lacticodeshydrogenase (LDH) and beta2microglobulinemia, chest x-ray, thoracic and abdominal CT scans, colonoscopy, small bowel barium x-ray, and bone marrow biopsy. In addition, endoscopic ultrasonography (EUS) was performed, according to the method described in a previous study. Presence or absence of perigastric lymph nodes was recorded.
Forty-three patients (20 men, 23 women; median age 56 years (range 23 92 years) with chronic gastritis without any macroscopic = -lesions were enrolled in the study as a control group (28 patients from the Henri Mondor Hospital and 15 patients from the Bordeaux Hospital). Written informed consent of non-opposition to use biological material for study purposes was obtained from all patients.
Histology and immunohistochemistry
Tissues analyzed were human gastric biopsies. Tissue specimens were fixed in formalin, paraffin-embedded and routinely processed for histological studies. In addition, gastric biopsies were snap-frozen in liquid nitrogen for genotypic studies. Hematoxylin and eosin stained sections were reviewed for all cases.
Histological diagnosis of GML was made according to the criteria defined by Isaacson .: presence of a diffuse infiltrate of CD20 et al + CD5 centrocyte-like B cells in the lamina propria with prominent lymphoepithelial lesions and reactive lymphoid follicles.
−
Immunohistochemistry was performed in all cases on paraffin sections. Presence of was assessed on modified Giemsa stained H. pylori sections and by culture.
After treatment, follow-up gastric biopsies were analyzed and tumoral response to treatment was assessed using the GELA histological grading system. Gastric biopsies of GML patients at diagnosis and of control group patients were evaluated for the severity of gastritis (activity, inflammation, atrophy, intestinal metaplasia, dysplasia, ) and graded on a 0 3 scale according to the Updated Sydney system. H. pylori -All gastric biopsies of GML patients at diagnosis and of the control group were analyzed for NOXmRNA expression. In addition, follow-up gastric biopsies of 10 GML patients were analysed at partial (1 rRD) or histological remission (3 CR/6 pMRD).
RNA extraction
Total RNAs were extracted from frozen tissue samples using the TRIzol reagent (Life Technologies, Cergy-Pontoise, France). Two g 
eal-time PCR
RNA extraction was performed using the RNeasy Mini-kit (Qiagen SA, Courtaboeuf, France) following the manufacturer s ' instructions. cDNA was generated using the High-Capacity cDNA Archive kit (Applied Biosystems, Courtaboeuf, France). Real-time quantitative PCRs were performed using Assays-on-Demand kits from Applied Biosystems for gene expression products of NOX2, NOX5 and a control endogen gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), designed with the corresponding sequences of the GenBank accession numbers Hs00166163_m1, Hs00225846_m1, Hs99999905_m1. TaqMan Minor Groove Binder probes were synthetized with the reporter dye FAM covalently linked to the 5 P ends and the non-fluorescent quencher at the 3 P ends, which were The different genes were all tested in duplicate for each patient. Data were normalized for the amount of GAPDH (2 ( CtNOX δ − δ ) using an ABIPrism pre-developed taqman assay reagent as already described.
CtGAPDH)
Detection of the t(11;18) fusion transcript
The presence of a t(11;18) translocation was determined by amplification and sequencing of the API2-MALT1 fusion transcript as previously published. For GML -positive patients eradication of infection was evaluated 2 months after the end of the treatment by H. pylori , H. pylori performing a new upper endoscopy with biopsy samples. If the infection was still present, a new eradication treatment was given.
Treatment of H. pylori-positive patients
H. pylori
The tumoral response was assessed 6 months after treatment by upper endoscopy with biopsy samples on residual lesions or on the previous location of the disease. 
Statistical analysis
The association between categorical variables was examined using the test. NOX2 and NOX5 gastric mRNA levels were compared X 2 for more than two groups by Kruskal Wallis analysis of variance and between two groups by the Mann Whitney test. Bivariate --correlations were tested by Spearman test between NOX2 and NOX5 mRNA levels. Differences with a p value of less than 0.05 were considered significant. All statistics were performed using SPSS 16.0F for Windows software (SPSS Inc., Chicago, IL, USA).
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